Study Finds GLP-1 Drugs Deliver Similar Heart and Kidney Benefits for People With Type 2 Diabetes
A major comparative effectiveness study has found that three widely used glucagon-like peptide-1 receptor agonists (GLP-1 RAs) , Liraglutide, Semaglutide…



